TickerFacts.

Adia Nutrition, Inc. (ADIA): Capital Expenditures

Annual figures by period end, from SEC filings.

$13.2K
Year ended 2025-12-31
$5.5K
Trailing 12 months to 2026-06-30
$21.8K2024-12-31: $21.8K2025-12-31: $13.2K$13.2K
2024-12-31 Capital Expenditures (USD) 2025-12-31
Period endedCapital ExpendituresChange YoYSource filing
2025-12-31$13.2K-39.5%2026-03-31, From 2025-01-01
2024-12-31$21.8Kn/a2026-03-31, From 2024-01-01

Capital Expenditures at similar companies

Companies with the same SEC industry code (Medicinal Chemicals & Botanical Products), reporting in the same currency, closest in revenue. Each shows its own latest fiscal year, so period ends differ.

CompanyYear endedCapital ExpendituresChange YoY
Adia Nutrition, Inc. (ADIA)2025-12-31$13.2K-39.5%
TFA Therapeutics, Inc. (RAJAF)2024-12-31$349.2K+9.3%
China Foods Holdings Ltd. (CFOO)2024-12-31$23.5Kn/m
Nutra Pharma Corp (NPHC)2025-12-31$26.1Kn/a
Functional Brands Inc. (MEHA)2025-12-31$8.5K+352.6%
Bon Natural Life Ltd (BON)2025-09-30$6.8K-3.1%
Charlie's Holdings, Inc. (CHUC)2025-12-31$23.0Kn/a
C21 Investments Inc. (CWLXF)2026-03-31$244.8K-39.8%
Leef Brands Inc. (LEEEF)2025-12-31$642.0K-89.2%

Compare ADIA, RAJAF, CFOO, NPHC side by side · Screen every company in Medicinal Chemicals & Botanical Products ↗